News Sentiment

42C sentiment intelligence

iX Biopharma Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 47 Balanced news tone 17 relevant articles
Exchange SES Singapore
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 0.40 Week of 19 Jun 2026
Weighted tone 47/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

83/100 classification confidence.

Company focus 17

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+8.2% over one week, +14.5% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

iX Biopharma Sets July 2026 Expiry for S$0.06 Warrants

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 83/100 classification
One-week reaction 8.2% Price confirming higher
Trend fit Trend active 14.5% over four weeks
Fair value 405.3% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 8
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 17
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 4
Singapore Business Review 4
Minichart 3
TipRanks 2
marketscreener.com 1
simplywall.st 1
NextInsight 1
TradingView 1

Event Lens

What the news is about

Classified themes
Market update 11
Deals and strategy 2
Earnings 2
Analyst action 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-17 of 17